TGF-β neutralization abrogates the inhibited DHEA production mediated by factors released from M. tuberculosis-stimulated PBMC

Annals of the New York Academy of Sciences

Volumn 1262, Issue 1, 2012, Pages 1-9

  D'Attilio, Luciano ^a   Bozza, Verónica V ^a   Santucci, Natalia ^a   Bongiovanni, Bettina ^a   Dídoli, Griselda ^a   Radcliffe, Stella ^b   Besedovsky, Hugo ^c   del Rey, Adriana ^c   Bottasso, Oscar ^a   Bay, María Luisa ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Hospital Centenario de Rosario   (Argentina)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cortisol; Dehydroepiandrosterone; NCI H295R cell line; TGF ; Tuberculosis

Indexed keywords

FORSKOLIN; HYDROCORTISONE; PRASTERONE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ADRENAL CELL; ANDROGEN RELEASE; ARTICLE; CELL CULTURE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE INHIBITION; HUMAN; HUMAN CELL; HYDROCORTISONE RELEASE; IMMUNE RESPONSE; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SERODIAGNOSIS; SUPERNATANT; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84864148823     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06644.x     Document Type: Article

References (37)

1. World Health Organization. 2009. Global Tuberculosis Control: Epidemiology, Strategy. World Health Organization. Geneva, Switzerland. Financing: WHO report 2009.
2. Flynn, J.L. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 84: 93-101.
3. Small, P.M. & P.I. Fujiwara. 2001. Management of tuberculosis in the United States. N. Engl. J. Med. 345: 189-200.
4. Baumann, S., A.N. Eddin & S.H.E. Kaufmann. 2006. Progress in tuberculosis vaccine development. Curr. Opin. Immunol. 18: 438-448.
5. Ottenhoff, T.H., F.A. Verreck, M.A. Hoeve & E. van de Vosse. 2005. Control of human host immunity to mycobacteria. Tuberculosis 85: 53-64.
6. North, R.J. & Y.J. Jung. 2004. Immunity to tuberculosis. Annu. Rev. Immunol. 22: 599-623.
7. Dheda, K., H. Booth, J.F. Huggett, et al. 2005. Lung remodeling in pulmonary tuberculosis. J. Infect. Dis. 192: 1201-1210.
8. Cadranel, J., C. Philippe, J. Perez, et al. 1990. In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients. Clin. Exp. Immunol. 81: 319-324.
9. Flynn, J.L., M.M. Goldstein, J. Chan, et al. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572.
10. Condos, R., W.N. Rom, Y.M. Liu & N.W. Schluger. 1998. Local immune responses correlate with presentation and outcome in tuberculosis. Am. J. Respir. Crit. Care Med. 157: 729-735.
11. Rook, G.A., R. Hernandez-Pando, K. Dheda & S.G. Teng. 2004. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol. 25: 483-488.
12. Boussiotis, V.A., E.Y. Tsai, E.J. Yunis, et al. 2000. IL-10 producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105: 1317-1325.
13. van Crevel, R., E. Karyadi, F. Preyers, et al. 2000. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J. Infect. Dis. 181: 1194-1197.
14. Balikó, Z., L. Szereday & J. Szekeres-Bartho. 1998. Th2 biased immune response in cases with active Mycobacterium tuberculosis infection and tuberculin anergy. FEMS Immunol. Med. Microbiol. 22: 199-204.
15. Bottasso, O., M.L. Bay, H. Besedovsky & A. del Rey. 2007. The immuno-endocrine component in the pathogenesis of tuberculosis. Scand. J. Immunol. 66: 166-175.
16. Chrousos, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351-1362.
17. Turnbull, A.V. & C.L. Rivier. 1999. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79: 1-71.
18. Besedovsky, H. & A. del Rey. 1996. Immune-neuro-endocrine interactions: facts and hypothesis. Endocr. Rev. 17: 64-101.
19. Ehrhart-Bornstein, M., J.P. Hinson, S.R. Bornstein, et al. 1998. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr. Rev. 19: 101-143.
20. Bornstein, S.R. & M. Ehrhart-Bornstein. 2000. Basic and clinical aspects of intraadrenal regulation of steroidogenesis. Z. Rheumatol. 59(Suppl. 2): 12-17.
21. Dillon, J. 2005. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr. Drug Targets Inflamm. Allergy 4: 377-385.
22. Howard, A.D. & B.S. Zwilling. 1999. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin. Exp. Immunol. 115: 428-434.
23. Actor, J.K., C.D. Leonard, V.E. Watson, et al. 2000. Cytokine mRNA expression and serum cortisol evaluation during murine lung inflammation induced by Mycobacterium tuberculosis. Comb. Chem. High Throughput Screen 3: 343-351.
24. Hernandez-Pando, R., M.D.L. Streber, H. Orozco, et al. 1998. The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in Balb/c mice. Immunology 95: 234-241.
25. Hernandez-Pando, R., H. Orozco, J. Honour, et al. 1995. Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis? FEMS Immunol. Med. Microbiol. 12: 63-72.
26. Mahuad, C., M.L. Bay, M.A. Farroni, et al. 2004. Cortisol and dehydroepiandrosterone affect the response of peripheral blood mononuclear cells to mycobacterial antigens during tuberculosis. Scand. J. Immunol. 60: 639-646.
27. Verbon, A., N. Juffermans, S. Van Deventer, et al. 1999. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 115: 110-113.
28. del Rey, A., C.V. Mahuad, V. Bozza, et al. 2007. Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav. Immun. 21: 171-179.
29. Lebrethon, M.C., C. Jaillard, D. Naville, et al. 1994. Effects of transforming growth factor-beta 1 on human adrenocortical fasciculata-reticularis cell differentiated functions. J. Clin. Endocrinol. Metab. 79: 1033-1039.
30. Dlugovitzky, D., M.L. Bay, L. Rateni, et al. 1999. In vitro synthesis of interferon-γ, interleukin-4, transforming growth factor-β, and interleukin 1-β by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand. J. Immunol. 49: 210-217.
31. Haidan, A., U. Hilbers, S.R. Bornstein & M. Ehrhart-Bornstein. 1998. Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP). Peptides 19: 1511-1517.
32. Baumann, H. & J. Gauldie. 1994. The acute phase response. Immunol. Today 15: 74-80.
33. Besedovsky, H. & A. del Rey. 1992. Immune- neuroendocrine circuits: integrative role of cytokines. Front. Neuroendocrinol. 13: 61-94.
34. Ramirez, F., D.J. Fowell, M. Puklavec, et al. 1996. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156: 2406-2412.
35. Padgett, D.A., J.F. Sheridan & R. Loria. 1995. Steroid hormone regulation of a polyclonal Th2 immune response. Ann. N.Y. Acad. Sci. 774: 323-325.
36. Bozza, V.V., L. D'Attilio, C.V. Mahuad, et al. 2007. Altered Cortisol/DHEA ratio in tuberculosis patients and its relationship with abnormalities in the mycobacterial-driven cytokine production by peripheral blood mononuclear cells. Scand. J. Immunol. 66: 97-103.
37. Toossi, Z. & J.J. Ellner. 1998. The role of TGF-β in the pathogenesis of human tuberculosis. Clin. Immunol. Immunopathol. 87: 107-114.